{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:21:11Z","timestamp":1772119271680,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK103564"],"award-info":[{"award-number":["R01 DK103564"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 494919"],"award-info":[{"award-number":["R01 494919"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL 102497"],"award-info":[{"award-number":["HL 102497"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00467-021-05075-y","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T03:03:23Z","timestamp":1623639803000},"page":"3933-3944","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association of circulating fibroblast growth factor-2 with progression of HIV-chronic kidney diseases in children"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2223-9584","authenticated-orcid":false,"given":"Patricio E.","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jharna R.","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,14]]},"reference":[{"key":"5075_CR1","first-page":"396","volume":"18","author":"PE Ray","year":"1998","unstructured":"Ray PE, Rakusan T, Loechelt BJ, Selby DM, Liu XH, Chandra RS (1998) Human immunodeficiency virus (HIV)-associated nephropathy in children from the Washington, D.C. area: 12 years\u2019 experience. Semin Nephrol 18:396\u2013405","journal-title":"Semin Nephrol"},{"key":"5075_CR2","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.semnephrol.2008.09.001","volume":"28","author":"MI McCulloch","year":"2008","unstructured":"McCulloch MI, Ray PE (2008) Kidney disease in HIV-positive children. Semin Nephrol 28:585\u2013594","journal-title":"Semin Nephrol"},{"key":"5075_CR3","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.ekir.2020.09.001","volume":"5","author":"H Beng","year":"2020","unstructured":"Beng H, Rakhmanina N, Moudgil A, Tuchman S, Ahn SY, Griffith C, Mims MM, Ray PE (2020) HIV-associated CKDs in children and adolescents. Kidney Int Rep 5:2292\u20132300","journal-title":"Kidney Int Rep"},{"key":"5075_CR4","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","volume":"329","author":"G Genovese","year":"2010","unstructured":"Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329:841\u2013845","journal-title":"Science"},{"key":"5075_CR5","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ekir.2019.04.002","volume":"4","author":"PM Ekulu","year":"2019","unstructured":"Ekulu PM, Nkoy AB, Betukumesu DK, Aloni MN, Makulo JRR, Sumaili EK, Mafuta EM, Elmonem MA, Arcolino FO, Kitetele FN, Lepira FB, van den Heuvel LP, Levtchenko EN (2019) APOL1 risk genotypes are associated with early kidney damage in children in Sub-Saharan Africa. Kidney Int Rep 4:930\u2013938","journal-title":"Kidney Int Rep"},{"key":"5075_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/QAI.0000000000001010","volume":"73","author":"MU Purswani","year":"2016","unstructured":"Purswani MU, Patel K, Winkler CA, Spector SA, Hazra R, Seage GR 3rd, Mofenson L, Karalius B, Scott GB, Van Dyke RB, Kopp JB, Pediatric HIVAIDS Cohort Study (2016) Brief report: APOL1 renal risk variants are associated with chronic kidney disease in children and youth with perinatal HIV infection. J Acquir Immune Defic Syndr 73:63\u201368","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5075_CR7","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1681\/ASN.2011040388","volume":"22","author":"JB Kopp","year":"2011","unstructured":"Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA (2011) APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 22:2129\u20132137","journal-title":"J Am Soc Nephrol"},{"key":"5075_CR8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jpeds.2007.11.007","volume":"152","author":"AI Chaparro","year":"2008","unstructured":"Chaparro AI, Mitchell CD, Abitbol CL, Wilkinson JD, Baldarrago G, Lopez E, Zilleruelo G (2008) Proteinuria in children infected with the human immunodeficiency virus. J Pediatr 152:844\u2013849","journal-title":"J Pediatr"},{"key":"5075_CR9","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s004670050749","volume":"13","author":"PE Ray","year":"1999","unstructured":"Ray PE, Liu XH, Xu L, Rakusan T (1999) Basic fibroblast growth factor in HIV-associated hemolytic uremic syndrome. Pediatr Nephrol 13:586\u2013593","journal-title":"Pediatr Nephrol"},{"key":"5075_CR10","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1089\/088922201300343717","volume":"17","author":"G Ascherl","year":"2001","unstructured":"Ascherl G, Sgadari C, Bugarini R, Bogner J, Schatz O, Ensoli B, Sturzl M (2001) Serum concentrations of fibroblast growth factor 2 are increased in HIV type 1-infected patients and inversely related to survival probability. AIDS Res Hum Retrovir 17:1035\u20131039","journal-title":"AIDS Res Hum Retrovir"},{"key":"5075_CR11","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/ki.1995.433","volume":"48","author":"W Kriz","year":"1995","unstructured":"Kriz W, Hahnel B, Rosener S, Elger M (1995) Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis. Kidney Int 48:1435\u20131450","journal-title":"Kidney Int"},{"key":"5075_CR12","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1177\/019262339302100508","volume":"21","author":"G Mazue","year":"1993","unstructured":"Mazue G, Newman AJ, Scampini G, Della Torre P, Hard GC, Iatropoulos MJ, Williams GM, Bagnasco SM (1993) The histopathology of kidney changes in rats and monkeys following intravenous administration of massive doses of FCE 26184, human basic fibroblast growth factor. Toxicol Pathol 21:490\u2013501","journal-title":"Toxicol Pathol"},{"key":"5075_CR13","doi-asserted-by":"publisher","first-page":"F289","DOI":"10.1152\/ajprenal.00382.2005","volume":"291","author":"Z Li","year":"2006","unstructured":"Li Z, Jerebtsova M, Liu XH, Tang P, Ray PE (2006) Novel cystogenic role of basic fibroblast growth factor in developing rodent kidneys. Am J Physiol Ren Physiol 291:F289\u2013F296","journal-title":"Am J Physiol Ren Physiol"},{"key":"5075_CR14","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1172\/JCI118351","volume":"96","author":"J Floege","year":"1995","unstructured":"Floege J, Kriz W, Schulze M, Susani M, Kerjaschki D, Mooney A, Couser WG, Koch KM (1995) Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy. J Clin Invest 96:2809\u20132819","journal-title":"J Clin Invest"},{"key":"5075_CR15","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/ki.1994.331","volume":"46","author":"PE Ray","year":"1994","unstructured":"Ray PE, Bruggeman LA, Weeks BS, Kopp JB, Bryant JL, Owens JW, Notkins AL, Klotman PE (1994) bFGF and its low affinity receptors in the pathogenesis of HIV-associated nephropathy in transgenic mice. Kidney Int 46:759\u2013772","journal-title":"Kidney Int"},{"key":"5075_CR16","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1097\/00002030-200005260-00008","volume":"14","author":"R Thiebaut","year":"2000","unstructured":"Thiebaut R, Morlat P, Jacqmin-Gadda H, Neau D, Mercie P, Dabis F, Chene G (2000) Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. Groupe d'Epidemiologie du SIDA en Aquitaine (GECSA). AIDS 14:971\u2013978","journal-title":"AIDS"},{"key":"5075_CR17","doi-asserted-by":"crossref","unstructured":"Bozic M, Betriu A, Bermudez-Lopez M, Ortiz A, Fernandez E, Valdivielso JM, NEFRONA investigators (2018) Association of FGF-2 concentrations with atheroma progression in chronic kidney disease patients. Clin J Am Soc Nephrol 13:577\u2013584","DOI":"10.2215\/CJN.07980717"},{"key":"5075_CR18","first-page":"R1008","volume":"258","author":"PE Ray","year":"1990","unstructured":"Ray PE, Castren E, Ruley EJ, Saavedra JM (1990) Different effects of sodium or chloride depletion on angiotensin II receptors in rats. Am J Phys 258:R1008\u2013R1015","journal-title":"Am J Phys"},{"key":"5075_CR19","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1046\/j.1523-1755.2001.0590051717.x","volume":"59","author":"XH Liu","year":"2001","unstructured":"Liu XH, Aigner A, Wellstein A, Ray PE (2001) Up-regulation of a fibroblast growth factor binding protein in children with renal diseases. Kidney Int 59:1717\u20131728","journal-title":"Kidney Int"},{"key":"5075_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1203\/00006450-199603000-00001","volume":"39","author":"AM Gonzalez","year":"1996","unstructured":"Gonzalez AM, Hill DJ, Logan A, Maher PA, Baird A (1996) Distribution of fibroblast growth factor (FGF)-2 and FGF receptor-1 messenger RNA expression and protein presence in the mid-trimester human fetus. Pediatr Res 39:375\u2013385","journal-title":"Pediatr Res"},{"key":"5075_CR21","first-page":"58","volume":"2","author":"M Pourghasem","year":"2013","unstructured":"Pourghasem M, Nasiri E, Sum S, Shafi H (2013) The assessment of early glycosaminoglycan concentration changes in the kidney of diabetic rats by critical electrolyte concentration staining. Int J Mol Cell Med 2:58\u201363","journal-title":"Int J Mol Cell Med"},{"key":"5075_CR22","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/ki.1986.264","volume":"30","author":"YS Kanwar","year":"1986","unstructured":"Kanwar YS, Caulin-Glaser T, Gallo GR, Lamm ME (1986) Interaction of immune complexes with glomerular heparan sulfate-proteoglycans. Kidney Int 30:842\u2013851","journal-title":"Kidney Int"},{"key":"5075_CR23","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1681\/ASN.2013070710","volume":"25","author":"X Xie","year":"2014","unstructured":"Xie X, Colberg-Poley AM, Das JR, Li J, Zhang A, Tang P, Jerebtsova M, Gutkind JS, Ray PE (2014) The basic domain of HIV-tat transactivating protein is essential for its targeting to lipid rafts and regulating fibroblast growth factor-2 signaling in podocytes isolated from children with HIV-1-associated nephropathy. J Am Soc Nephrol 25:1800\u20131813","journal-title":"J Am Soc Nephrol"},{"key":"5075_CR24","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1681\/ASN.2016050564","volume":"28","author":"J Li","year":"2017","unstructured":"Li J, Das JR, Tang P, Han Z, Jaiswal JK, Ray PE (2017) Transmembrane TNF-alpha facilitates HIV-1 infection of podocytes cultured from children with HIV-associated nephropathy. J Am Soc Nephrol 28:862\u2013875","journal-title":"J Am Soc Nephrol"},{"key":"5075_CR25","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1046\/j.1523-1755.1998.00900.x","volume":"53","author":"PE Ray","year":"1998","unstructured":"Ray PE, Liu XH, Henry D, Dye L 3rd, Xu L, Orenstein JM, Schuztbank TE (1998) Infection of human primary renal epithelial cells with HIV-1 from children with HIV-associated nephropathy. Kidney Int 53:1217\u20131229","journal-title":"Kidney Int"},{"key":"5075_CR26","doi-asserted-by":"crossref","unstructured":"Tang P, Das JR, Li J, Yu J, Ray PE (2020) An HIV-Tat inducible mouse model system of childhood HIV-associated nephropathy. Dis Model Mech:13","DOI":"10.1101\/2020.05.06.081851"},{"key":"5075_CR27","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1021\/bi00430a047","volume":"28","author":"P Bashkin","year":"1989","unstructured":"Bashkin P, Doctrow S, Klagsbrun M, Svahn CM, Folkman J, Vlodavsky I (1989) Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 28:1737\u20131743","journal-title":"Biochemistry"},{"key":"5075_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF00046362","volume":"9","author":"PA D\u2019Amore","year":"1990","unstructured":"D\u2019Amore PA (1990) Modes of FGF release in vivo and in vitro. Cancer Metastasis Rev 9:227\u2013238","journal-title":"Cancer Metastasis Rev"},{"key":"5075_CR29","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.4049\/jimmunol.154.7.3582","volume":"154","author":"F Samaniego","year":"1995","unstructured":"Samaniego F, Markham PD, Gallo RC, Ensoli B (1995) Inflammatory cytokines induce AIDS-Kaposi\u2019s sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi\u2019s sarcoma-like lesion formation in nude mice. J Immunol 154:3582\u20133592","journal-title":"J Immunol"},{"key":"5075_CR30","doi-asserted-by":"publisher","first-page":"F245","DOI":"10.1152\/ajprenal.00186.2011","volume":"301","author":"CM Bates","year":"2011","unstructured":"Bates CM (2011) Role of fibroblast growth factor receptor signaling in kidney development. Am J Physiol Ren Physiol 301:F245\u2013F251","journal-title":"Am J Physiol Ren Physiol"},{"key":"5075_CR31","first-page":"R819","volume":"294","author":"S Villanueva","year":"2008","unstructured":"Villanueva S, Cespedes C, Gonzalez AA, Roessler E, Vio CP (2008) Inhibition of bFGF-receptor type 2 increases kidney damage and suppresses nephrogenic protein expression after ischemic acute renal failure. Am J Phys Regul Integr Comp Phys 294:R819\u2013R828","journal-title":"Am J Phys Regul Integr Comp Phys"},{"key":"5075_CR32","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1111\/jcmm.13203","volume":"21","author":"XH Tan","year":"2017","unstructured":"Tan XH, Zheng XM, Yu LX, He J, Zhu HM, Ge XP, Ren XL, Ye FQ, Bellusci S, Xiao J, Li XK, Zhang JS (2017) Fibroblast growth factor 2 protects against renal ischaemia\/reperfusion injury by attenuating mitochondrial damage and proinflammatory signalling. J Cell Mol Med 21:2909\u20132925","journal-title":"J Cell Mol Med"},{"key":"5075_CR33","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.1957172","volume":"254","author":"P Cuevas","year":"1991","unstructured":"Cuevas P, Carceller F, Ortega S, Zazo M, Nieto I, Gimenez-Gallego G (1991) Hypotensive activity of fibroblast growth factor. Science 254:1208\u20131210","journal-title":"Science"},{"key":"5075_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nm0298-201","volume":"4","author":"M Zhou","year":"1998","unstructured":"Zhou M, Sutliff RL, Paul RJ, Lorenz JN, Hoying JB, Haudenschild CC, Yin M, Coffin JD, Kong L, Kranias EG, Luo W, Boivin GP, Duffy JJ, Pawlowski SA, Doetschman T (1998) Fibroblast growth factor 2 control of vascular tone. Nat Med 4:201\u2013207","journal-title":"Nat Med"},{"key":"5075_CR35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1161\/HYPERTENSIONAHA.117.10268","volume":"71","author":"E Tassi","year":"2018","unstructured":"Tassi E, Lai EY, Li L, Solis G, Chen Y, Kietzman WE, Ray PE, Riegel AT, Welch WJ, Wilcox CS, Wellstein A (2018) Blood pressure control by a secreted FGFBP1 (fibroblast growth factor-binding protein). Hypertension 71:160\u2013167","journal-title":"Hypertension"},{"key":"5075_CR36","first-page":"R105","volume":"290","author":"PE Ray","year":"2006","unstructured":"Ray PE, Tassi E, Liu XH, Wellstein A (2006) Role of fibroblast growth factor-binding protein in the pathogenesis of HIV-associated hemolytic uremic syndrome. Am J Phys Regul Integr Comp Phys 290:R105\u2013R113","journal-title":"Am J Phys Regul Integr Comp Phys"},{"key":"5075_CR37","first-page":"528","volume":"71","author":"H Morita","year":"1994","unstructured":"Morita H, Shinzato T, David G, Mizutani A, Habuchi H, Fujita Y, Ito M, Asai J, Maeda K, Kimata K (1994) Basic fibroblast growth factor-binding domain of heparan sulfate in the human glomerulosclerosis and renal tubulointerstitial fibrosis. Lab Investig 71:528\u2013535","journal-title":"Lab Investig"},{"key":"5075_CR38","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.jpedsurg.2004.08.014","volume":"39","author":"H Kobayashi","year":"2004","unstructured":"Kobayashi H, Miyakita H, Yamataka A, Koga H, Lane GJ, Miyano T (2004) Serum basic fibroblast growth factor as a marker of reflux nephropathy. J Pediatr Surg 39:1853\u20131855","journal-title":"J Pediatr Surg"},{"key":"5075_CR39","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/1096-8628(20000717)93:2<132::AID-AJMG10>3.0.CO;2-#","volume":"93","author":"GK Gupta","year":"2000","unstructured":"Gupta GK, Milner L, Linshaw MA, McCauley RG, Connors S, Folkman J, Bianchi DW (2000) Urinary basic fibroblast growth factor: a noninvasive marker of progressive cystic renal disease in a child. Am J Med Genet 93:132\u2013135","journal-title":"Am J Med Genet"},{"key":"5075_CR40","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1681\/ASN.V133699","volume":"13","author":"P Ray","year":"2002","unstructured":"Ray P, Acheson D, Chitrakar R, Cnaan A, Gibbs K, Hirschman GH, Christen E, Trachtman H, Investigators of the Hemolytic Uremic Syndrome-Synsorb PK Multicenter Clinical Trial (2002) Basic fibroblast growth factor among children with diarrhea-associated hemolytic uremic syndrome. J Am Soc Nephrol 13:699\u2013707","journal-title":"J Am Soc Nephrol"},{"key":"5075_CR41","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s00467-013-2543-3","volume":"28","author":"K Wai","year":"2013","unstructured":"Wai K, Soler-Garcia AA, Perazzo S, Mattison P, Ray PE (2013) A pilot study of urinary fibroblast growth factor-2 and epithelial growth factor as potential biomarkers of acute kidney injury in critically ill children. Pediatr Nephrol 28:2189\u20132198","journal-title":"Pediatr Nephrol"},{"key":"5075_CR42","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/08977198909029125","volume":"1","author":"GF Whalen","year":"1989","unstructured":"Whalen GF, Shing Y, Folkman J (1989) The fate of intravenously administered bFGF and the effect of heparin. Growth Factors 1:157\u2013164","journal-title":"Growth Factors"},{"issue":"Suppl 1","key":"5075_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/ndt\/14.suppl_1.33","volume":"14","author":"T Sasaki","year":"1999","unstructured":"Sasaki T, Hatta H, Osawa G (1999) Cytokines and podocyte injury: the mechanism of fibroblast growth factor 2-induced podocyte injury. Nephrol Dial Transplant 14(Suppl 1):33\u201334","journal-title":"Nephrol Dial Transplant"},{"key":"5075_CR44","doi-asserted-by":"publisher","first-page":"e0153837","DOI":"10.1371\/journal.pone.0153837","volume":"11","author":"JR Das","year":"2016","unstructured":"Das JR, Gutkind JS, Ray PE (2016) Circulating fibroblast growth factor-2, HIV-Tat, and vascular endothelial cell growth factor-A in HIV-infected children with renal disease activate Rho-A and Src in cultured renal endothelial cells. PLoS One 11:e0153837","journal-title":"PLoS One"},{"key":"5075_CR45","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1161\/01.RES.0000112965.70691.AC","volume":"94","author":"CC Chua","year":"2004","unstructured":"Chua CC, Rahimi N, Forsten-Williams K, Nugent MA (2004) Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2. Circ Res 94:316\u2013323","journal-title":"Circ Res"},{"key":"5075_CR46","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1172\/JCI200113738","volume":"108","author":"RV Iozzo","year":"2001","unstructured":"Iozzo RV, San Antonio JD (2001) Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J Clin Invest 108:349\u2013355","journal-title":"J Clin Invest"},{"key":"5075_CR47","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/ng.792","volume":"43","author":"K Okamoto","year":"2011","unstructured":"Okamoto K, Tokunaga K, Doi K, Fujita T, Suzuki H, Katoh T, Watanabe T, Nishida N, Mabuchi A, Takahashi A, Kubo M, Maeda S, Nakamura Y, Noiri E (2011) Common variation in GPC5 is associated with acquired nephrotic syndrome. Nat Genet 43:459\u2013463","journal-title":"Nat Genet"},{"key":"5075_CR48","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.ajpath.2015.03.025","volume":"185","author":"K Okamoto","year":"2015","unstructured":"Okamoto K, Honda K, Doi K, Ishizu T, Katagiri D, Wada T, Tomita K, Ohtake T, Kaneko T, Kobayashi S, Nangaku M, Tokunaga K, Noiri E (2015) Glypican-5 increases susceptibility to nephrotic damage in diabetic kidney. Am J Pathol 185:1889\u20131898","journal-title":"Am J Pathol"},{"key":"5075_CR49","doi-asserted-by":"publisher","first-page":"835","DOI":"10.2353\/ajpath.2006.050479","volume":"168","author":"SI Zittermann","year":"2006","unstructured":"Zittermann SI, Issekutz AC (2006) Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression. Am J Pathol 168:835\u2013846","journal-title":"Am J Pathol"},{"key":"5075_CR50","doi-asserted-by":"publisher","first-page":"6547","DOI":"10.1073\/pnas.92.14.6547","volume":"92","author":"GE Peoples","year":"1995","unstructured":"Peoples GE, Blotnick S, Takahashi K, Freeman MR, Klagsbrun M, Eberlein TJ (1995) T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. Proc Natl Acad Sci U S A 92:6547\u20136551","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5075_CR51","doi-asserted-by":"publisher","first-page":"F253","DOI":"10.1152\/ajprenal.00429.2007","volume":"294","author":"JW Celie","year":"2008","unstructured":"Celie JW, Reijmers RM, Slot EM, Beelen RH, Spaargaren M, Ter Wee PM, Florquin S, van den Born J (2008) Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria. Am J Physiol Ren Physiol 294:F253\u2013F263","journal-title":"Am J Physiol Ren Physiol"},{"key":"5075_CR52","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1073\/pnas.1820414116","volume":"116","author":"J Chun","year":"2019","unstructured":"Chun J, Zhang JY, Wilkins MS, Subramanian B, Riella C, Magraner JM, Alper SL, Friedman DJ, Pollak MR (2019) Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity. Proc Natl Acad Sci U S A 116:3712\u20133721","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5075_CR53","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1097\/QAD.0000000000002589","volume":"34","author":"K Hughes","year":"2020","unstructured":"Hughes K, Akturk G, Gnjatic S, Chen B, Klotman M, Blasi M (2020) Proliferation of HIV-infected renal epithelial cells following virus acquisition from infected macrophages. AIDS 34:1581\u20131591","journal-title":"AIDS"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05075-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-05075-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05075-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T18:04:16Z","timestamp":1675447456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-05075-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,14]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5075"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-05075-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.12.08.20246280","asserted-by":"object"}]},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,14]]},"assertion":[{"value":"22 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare they have no competing interest, conflict of interest, or disclosures including financial, consultant, institutional, and other relationships that might lead to bias or conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}